ID   SRPK2_HUMAN             Reviewed;         688 AA.
AC   P78362; A8MVX2; O75220; O75221; Q6NUL0; Q6V1X2; Q8IYQ3;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 3.
DT   05-OCT-2010, entry version 98.
DE   RecName: Full=Serine/threonine-protein kinase SRPK2;
DE            EC=2.7.11.1;
DE   AltName: Full=SFRS protein kinase 2;
DE   AltName: Full=Serine/arginine-rich protein-specific kinase 2;
DE            Short=SR-protein-specific kinase 2;
GN   Name=SRPK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RC   TISSUE=Fetal brain;
RX   MEDLINE=98139536; PubMed=9472028; DOI=10.1083/jcb.140.4.737;
RA   Wang H.-Y., Lin W., Dyck J.A., Yeakley J.M., Songyang Z.,
RA   Cantley L.C., Fu X.-D.;
RT   "SRPK2: a differentially expressed SR protein-specific kinase involved
RT   in mediating the interaction and localization of pre-mRNA splicing
RT   factors in mammalian cells.";
RL   J. Cell Biol. 140:737-750(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22737999; PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 1-99 (ISOFORM 2).
RC   TISSUE=Retinoblastoma, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-537 (ISOFORM 1).
RC   TISSUE=Testis;
RA   Sha J.H., Zhou Z.M., Li J.M.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION.
RX   PubMed=12134018; DOI=10.1128/JVI.76.16.8124-8137.2002;
RA   Daub H., Blencke S., Habenberger P., Kurtenbach A., Dennenmoser J.,
RA   Wissing J., Ullrich A., Cotten M.;
RT   "Identification of SRPK1 and SRPK2 as the major cellular protein
RT   kinases phosphorylating hepatitis B virus core protein.";
RL   J. Virol. 76:8124-8137(2002).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-319, AND MASS
RP   SPECTROMETRY.
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-380; SER-494; SER-497
RP   AND THR-547, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-494 AND SER-497, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-494; SER-497 AND
RP   THR-498, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-494, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-43; ASP-243; PRO-426; PHE-486 AND
RP   THR-515.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates RS domain-containing proteins, such as
CC       SFRS1 and SFRS2 on serine residues. Role in spliceosome assembly
CC       and in mediating the trafficking of splicing factors. Appears to
CC       mediate HBV core protein phosphorylation which is a prerequisite
CC       for pregenomic RNA encapsidation into viral capsids.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Ser-52 and Ser-
CC       588 (By similarity).
CC   -!- INTERACTION:
CC       Q15287:RNPS1; NbExp=1; IntAct=EBI-593303, EBI-395959;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78362-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78362-2; Sequence=VSP_039386;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, moderately
CC       expressed in heart and skeletal muscle and at low levels in lung,
CC       liver, and kidney.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ63886.1; Type=Miscellaneous discrepancy; Note=The cDNA appears to contain a duplicated region;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U88666; AAC05299.1; -; mRNA.
DR   EMBL; AC005070; AAC29140.1; -; Genomic_DNA.
DR   EMBL; AC005070; AAC29141.1; -; Genomic_DNA.
DR   EMBL; AC004884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073138; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471070; EAW83359.1; -; Genomic_DNA.
DR   EMBL; BC035214; AAH35214.1; -; mRNA.
DR   EMBL; BC068547; AAH68547.1; -; mRNA.
DR   EMBL; BE781215; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AY354201; AAQ63886.1; ALT_SEQ; mRNA.
DR   IPI; IPI00333420; -.
DR   IPI; IPI00396412; -.
DR   RefSeq; NP_872633.1; -.
DR   RefSeq; NP_872634.1; -.
DR   UniGene; Hs.285197; -.
DR   PDB; 2X7G; X-ray; 2.50 A; A=51-688.
DR   PDBsum; 2X7G; -.
DR   ProteinModelPortal; P78362; -.
DR   SMR; P78362; 64-283, 504-688.
DR   IntAct; P78362; 4.
DR   MINT; MINT-1468300; -.
DR   STRING; P78362; -.
DR   PhosphoSite; P78362; -.
DR   PRIDE; P78362; -.
DR   Ensembl; ENST00000336613; ENSP00000337679; ENSG00000135250.
DR   Ensembl; ENST00000357311; ENSP00000349863; ENSG00000135250.
DR   Ensembl; ENST00000393651; ENSP00000377262; ENSG00000135250.
DR   Ensembl; ENST00000489828; ENSP00000419791; ENSG00000135250.
DR   GeneID; 6733; -.
DR   KEGG; hsa:6733; -.
DR   UCSC; uc003vcw.1; human.
DR   CTD; 6733; -.
DR   GeneCards; GC07M104751; -.
DR   HGNC; HGNC:11306; SRPK2.
DR   HPA; HPA015522; -.
DR   HPA; HPA020876; -.
DR   MIM; 602980; gene.
DR   PharmGKB; PA36130; -.
DR   eggNOG; prNOG10386; -.
DR   HOVERGEN; HBG108512; -.
DR   PhylomeDB; P78362; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 26266; -.
DR   ArrayExpress; P78362; -.
DR   Bgee; P78362; -.
DR   CleanEx; HS_SRPK2; -.
DR   Genevestigator; P78362; -.
DR   GermOnline; ENSG00000135250; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0000245; P:spliceosome assembly; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Differentiation; Kinase; mRNA processing; mRNA splicing;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    688       Serine/threonine-protein kinase SRPK2.
FT                                /FTId=PRO_0000086677.
FT   DOMAIN       81    684       Protein kinase.
FT   NP_BIND      87     95       ATP (By similarity).
FT   ACT_SITE    214    214       Proton acceptor (By similarity).
FT   BINDING     110    110       ATP (By similarity).
FT   MOD_RES      52     52       Phosphoserine; by CK2 (By similarity).
FT   MOD_RES     319    319       Phosphotyrosine.
FT   MOD_RES     380    380       Phosphoserine.
FT   MOD_RES     494    494       Phosphoserine.
FT   MOD_RES     497    497       Phosphoserine.
FT   MOD_RES     498    498       Phosphothreonine.
FT   MOD_RES     547    547       Phosphothreonine.
FT   MOD_RES     588    588       Phosphoserine; by CK2 (By similarity).
FT   VAR_SEQ       1     13       MSVNSEKSSSSER -> MSSRKVLAIQARKRRPKREKHPKK
FT                                (in isoform 2).
FT                                /FTId=VSP_039386.
FT   VARIANT      43     43       P -> L (in dbSNP:rs34699980).
FT                                /FTId=VAR_041114.
FT   VARIANT     243    243       G -> D (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041115.
FT   VARIANT     426    426       T -> P (in dbSNP:rs55743527).
FT                                /FTId=VAR_041116.
FT   VARIANT     486    486       S -> F (in dbSNP:rs56112661).
FT                                /FTId=VAR_041117.
FT   VARIANT     515    515       P -> T (in dbSNP:rs56017595).
FT                                /FTId=VAR_041118.
FT   VARIANT     608    608       S -> N (in dbSNP:rs1050413).
FT                                /FTId=VAR_060390.
FT   VARIANT     615    615       L -> I (in dbSNP:rs1050418).
FT                                /FTId=VAR_057111.
FT   CONFLICT    137    137       P -> R (in Ref. 4; AAH68547).
FT   CONFLICT    236    237       AT -> P (in Ref. 1; AAC05299).
FT   CONFLICT    521    521       A -> R (in Ref. 1; AAC05299).
FT   CONFLICT    601    601       H -> L (in Ref. 2; AAC29141).
FT   CONFLICT    608    609       SI -> KV (in Ref. 2; AAC29141).
FT   CONFLICT    612    616       HFALS -> KYAML (in Ref. 2; AAC29141).
FT   CONFLICT    621    621       R -> K (in Ref. 2; AAC29141).
FT   CONFLICT    625    627       NRR -> TRK (in Ref. 2; AAC29141).
FT   CONFLICT    640    640       S -> G (in Ref. 4; AAH68547).
FT   CONFLICT    681    681       Missing (in Ref. 1; AAC05299).
SQ   SEQUENCE   688 AA;  77527 MW;  ACCAF2A887444EC2 CRC64;
     MSVNSEKSSS SERPEPQQKA PLVPPPPPPP PPPPPPLPDP TPPEPEEEIL GSDDEEQEDP
     ADYCKGGYHP VKIGDLFNGR YHVIRKLGWG HFSTVWLCWD MQGKRFVAMK VVKSAQHYTE
     TALDEIKLLK CVRESDPSDP NKDMVVQLID DFKISGMNGI HVCMVFEVLG HHLLKWIIKS
     NYQGLPVRCV KSIIRQVLQG LDYLHSKCKI IHTDIKPENI LMCVDDAYVR RMAAEATEWQ
     KAGAPPPSGS AVSTAPQQKP IGKISKNKKK KLKKKQKRQA ELLEKRLQEI EELEREAERK
     IIEENITSAA PSNDQDGEYC PEVKLKTTGL EEAAEAETAK DNGEAEDQEE KEDAEKENIE
     KDEDDVDQEL ANIDPTWIES PKTNGHIENG PFSLEQQLDD EDDDEEDCPN PEEYNLDEPN
     AESDYTYSSS YEQFNGELPN GRHKIPESQF PEFSTSLFSG SLEPVACGSV LSEGSPLTEQ
     EESSPSHDRS RTVSASSTGD LPKAKTRAAD LLVNPLDPRN ADKIRVKIAD LGNACWVHKH
     FTEDIQTRQY RSIEVLIGAG YSTPADIWST ACMAFELATG DYLFEPHSGE DYSRDEDHIA
     HIIELLGSIP RHFALSGKYS REFFNRRGEL RHITKLKPWS LFDVLVEKYG WPHEDAAQFT
     DFLIPMLEMV PEKRASAGEC LRHPWLNS
//
